低磷酸酯酶症中的转子下及股骨干骨折并非非典型
该研究基于150例低磷酸酯酶症(HPP)患者的横断面真实世界数据,其中15例发生过转子下或股骨干骨折,共评估25处骨折。结果显示88%的骨折形态符合非典型股骨骨折(AFF)定义标准,疾病内在风险包括常染色体隐性儿童期起病HPP、碱性磷酸酶≤20 U/l、吡哆醛5'-磷酸>正常上限3倍及高腰椎骨密度;作者认为严重HPP中应宽松筛查此类骨折,并避免双膦酸盐和维生素D缺乏。
要点
- HPP患者转子下/股骨干骨折形态88%符合AFF定义标准。
- 疾病内在风险包括常染色体隐性儿童期起病、ALP≤20 U/l、PLP>正常上限3倍及高腰椎BMD。
核心结论
- HPP中转子下及股骨干骨折风险增加似乎源于骨代谢受损及疾病相关骨畸形两方面。
- 在严重HPP中,宽松筛查此类骨折似乎是可取的。
- 应避免双膦酸盐和维生素D缺乏。
- 骨折愈合受损,需要审慎考虑药物和手术方案。
研究设计与样本
- 基于真实世界数据的横断面评估,纳入150例HPP患者,其中15例至少发生过一次转子下或股骨干骨折,共评估25处骨折。
- 对15例患者的病历进行详细回顾,提取病史、基因型、实验室检查、骨密度(DXA)、股骨几何形态影像数据及骨折病因与愈合的临床信息。
主要发现
- 15例患者中10例记录为双侧骨折,共25处骨折用于评估。
- 骨折形态在88%的病例中符合AFF定义标准。
- 股骨几何形态显示股骨颈干角减小和股骨偏距增加,为既往在AFF中描述的风险因素。
关键数值与推荐
- 疾病内在风险因素包括常染色体隐性、儿童期起病HPP、碱性磷酸酶(ALP)≤20 U/l、吡哆醛5'-磷酸(PLP)>正常上限3倍以及高腰椎骨密度。
- 骨折形态在88%的病例中符合AFF定义标准。
临床怎么用
- 作者认为,在严重HPP中宽松筛查此类骨折似乎是可取的。
- 作者认为,应避免双膦酸盐和维生素D缺乏。
- 作者认为,骨折愈合受损,需要审慎考虑药物和手术方案。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Risk for subtrochanteric and diaphyseal femoral fractures is considered increased in patients with hypophosphatasia (HPP). Evaluating a large cohort of HPP patients, we could for the first time quantify the prevalcence and identify both morphometric features as well as predisposing factors for this complication of severe HPP. INTRODUCTION: Subtrochanteric and diaphyseal femoral fractures have been associated with both, long-term antiresorptive treatment and metabolic bone disorders, specifically Hypophosphatasia (HPP). Building on a cross-sectional evaluation of real-world data, this study reports risk factors, prevalence, treatment outcome and morphometric particularities for such fractures in HPP as compared to Atypical Femoral Fractures (AFF) in long-term antiresorptive treatment. METHODS: For 15 out of 150 HPP patients identified with having experienced at least one such fracture, medical records were reviewed in detail, extracting medical history, genotype, lab assessments, bone mineral density (DXA), radiographic data on femoral geometry and clinical aspects of fracture etiology and healing. RESULTS: Bilateral fractures were documented in 10 of these 15 patients, yielding a total of 25 fractures for evaluation. Disease-inherent risk factors included autosomal-recessive, childhood onset HPP, apparently low alkaline phosphatase (ALP) ≤ 20 U/l and substantially elevated pyridoxal 5'-phosphate (PLP) > 3 times upper limit of normal as well as high lumbar spine BMD. Fracture morphology met definition criteria for AFF in 88% of cases. Femoral geometry revealed additional risk factors previously described for AFF, including decreased femoral neck-shaft angle and increased femoral offset. Extrinsic risk factors include Hypovitaminosis D (80%) and pre-treatment with bisphosphonates (46,7%) and Proton-Pump Inhibitors (40%). CONCLUSIONS: Increased risk for subtrochanteric and diaphyseal femoral fractures in HPP appears to result from both compromised bone metabolism as well as disease-associated bone deformities. In severe HPP, generous screening for such fractures seems advisable. Bisphosphonates and Hypovitaminosis D should be avoided. Healing is compromised and requires mindful consideration of both pharmacological and surgical options.
引用
- Genest F, Seefried L. Subtrochanteric and diaphyseal femoral fractures in hypophosphatasia-not atypical at all. Osteoporos Int. 2018. PMID: 29774402. doi:10.1007/s00198-018-4552-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。